Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment

Davida F Kruger,1 Susan LaRue,2,3 Phil Estepa31Henry Ford Health System, Detroit, MI, USA; 2Amylin Pharmaceuticals, San Diego, CA, USA; 3AstraZeneca, San Diego, CA, USAAbstract: Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kruger DF, LaRue S, Estepa P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/c4101dd3e397480987d143c0013dfd54
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!